Personalized Surgical Management of Genito-Urinary Cancers

Dear Colleagues,

The surgical management of genito-urinary (GU) cancers has seen much development over the last decades. Novel treatment approaches are gaining space and interest, moving from mini-invasive surgery and robotic platforms spreading to organ-sparing treatments and multimodality. Today, surgical stress and invasiveness are progressively reducing, moving progressively to single-port and extraperitoneal approaches to manage prostate and kidney cancers. At the same time robotics, digital endourology and laser improvements are changing scenarios in urothelial cancers.  The introduction of machine learning and artificial intelligence are awaited to add information and integrated surgical procedures. Moreover, a new attention to the quality of life, precise surgical patient selection and early recovery have similarly gained popularity in clinical practice, with a renewed focus on personalized interventions and reduced morbidity. Finally, new insights derived from adjuvant and neoadjuvant systemic therapies and immunotherapy have highlighted novel oncological strategies. This Special Issue presents up-to-date summaries regarding the personalized surgical management of GU cancers and the development of patient-centered management from preoperative, intraoperative and postoperative aspects.

Dr. Nazario Foschi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• genito-urinary cancers
• personalized medicine
• minimally invasive surgery
• perioperative care
• precision surgery
• integrated therapies